28th Conference on Retroviruses and Opportunistic Infections (CROI 2021) virtual

6–10 March 2021

Introduction

These reports concludes our coverage from the CROI 2021 virtual conference.

All conference materials are now available as open access documents on the CROI website, including webcasts.
https://www.croiconference.org

Articles in this issue of HTB are:

• No differences in outcomes among women with and without HIV with high-risk pregnancies and COVID-19
• Dolutegravir-based regimens safe and effective in pregnancy and postpartum
• Dolutegravir superior to standard of care in children and adolescents: results from the ODYSSEY trial